2-219222435-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001077198.3(ATG9A):c.1864G>A(p.Ala622Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000121 in 1,569,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001077198.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG9A | NM_001077198.3 | c.1864G>A | p.Ala622Thr | missense_variant | Exon 12 of 16 | ENST00000361242.9 | NP_001070666.1 | |
ATG9A | NM_024085.5 | c.1864G>A | p.Ala622Thr | missense_variant | Exon 11 of 15 | NP_076990.4 | ||
ATG9A | NR_104255.2 | n.1988G>A | non_coding_transcript_exon_variant | Exon 12 of 16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG9A | ENST00000361242.9 | c.1864G>A | p.Ala622Thr | missense_variant | Exon 12 of 16 | 2 | NM_001077198.3 | ENSP00000355173.4 | ||
ENSG00000284820 | ENST00000446716.5 | n.109G>A | non_coding_transcript_exon_variant | Exon 2 of 22 | 2 | ENSP00000398528.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000286 AC: 6AN: 209872Hom.: 0 AF XY: 0.0000264 AC XY: 3AN XY: 113680
GnomAD4 exome AF: 0.00000565 AC: 8AN: 1416990Hom.: 0 Cov.: 32 AF XY: 0.00000571 AC XY: 4AN XY: 701134
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1864G>A (p.A622T) alteration is located in exon 12 (coding exon 10) of the ATG9A gene. This alteration results from a G to A substitution at nucleotide position 1864, causing the alanine (A) at amino acid position 622 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at